MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527834 | Name: CH-38083

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CH-38083 is a selective, potent antagonist of alpha-2 adrenoceptors.

Chemical Structure

CH-38083
CH-38083
CAS#104786-63-2

Theoretical Analysis

MedKoo Cat#: 527834

Name: CH-38083

CAS#: 104786-63-2

Chemical Formula: C18H24ClNO3

Exact Mass: 337.1445

Molecular Weight: 337.84

Elemental Analysis: C, 63.99; H, 7.16; Cl, 10.49; N, 4.15; O, 14.21

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CH38083; CH 38083; CH-38083
IUPAC/Chemical Name
6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizin-11-ol, 5,8,8a,9,10,11,12,12a,13,13a-decahydro-, hydrochloride, (8aS-(8aalpha,11alpha,12aalpha,13aalpha))-
InChi Key
MSHVJMFWPHDENI-AFHKOZSWSA-N
InChi Code
InChI=1S/C18H23NO3.ClH/c20-14-2-1-12-9-19-4-3-11-7-17-18(22-10-21-17)8-15(11)16(19)6-13(12)5-14;/h7-8,12-14,16,20H,1-6,9-10H2;1H/t12-,13+,14+,16+;/m1./s1
SMILES Code
O[C@@H](CC1)C[C@]2([H])[C@@]1([H])CN3CCC4=C(C=C5OCOC5=C4)[C@]3([H])C2.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 337.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Vizi ES, Zsilla G, Caron MG, Kiss JP. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J Neurosci. 2004 Sep 8;24(36):7888-94. PubMed PMID: 15356201. 2: Selmeczy Z, Szelényi J, Vizi ES. Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance. Eur J Pharmacol. 2003 May 23;469(1-3):175-81. PubMed PMID: 12782200. 3: Vizi ES, Katona I, Freund TF. Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung. Eur J Pharmacol. 2001 Nov 16;431(2):237-44. PubMed PMID: 11728431. 4: Vizi ES, Szelényi J, Selmeczy ZS, Papp Z, Németh ZH, Haskó G. Enhanced tumor necrosis factor-alpha-specific and decreased interleukin-10-specific immune responses to LPS during the third trimester of pregnancy in mice. J Endocrinol. 2001 Nov;171(2):355-61. PubMed PMID: 11691656. 5: Banik RK, Sato J, Yajima H, Mizumura K. Differences between the Lewis and Sprague-Dawley rats in chronic inflammation induced norepinephrine sensitivity of cutaneous C-fiber nociceptors. Neurosci Lett. 2001 Feb 16;299(1-2):21-4. PubMed PMID: 11166928. 6: Taoda M, Adachi YU, Uchihashi Y, Watanabe K, Satoh T, Vizi ES. Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor. Neurochem Int. 2001 Apr;38(4):317-22. PubMed PMID: 11137626. 7: Szelényi J, Kiss JP, Puskás E, Selmeczy Z, Szelényi M, Vizi ES. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. Neuroreport. 2000 Nov 9;11(16):3565-8. PubMed PMID: 11095519. 8: Gyires K, Müllner K, Fürst S, Rónai AZ. Alpha-2 adrenergic and opioid receptor-mediated gastroprotection. J Physiol Paris. 2000 Mar-Apr;94(2):117-21. PubMed PMID: 10791692. 9: Szelényi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J Neuroimmunol. 2000 Feb 1;103(1):34-40. PubMed PMID: 10674987. 10: Sperlágh B, Sershen H, Lajtha A, Vizi ES. Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by alpha2-adrenoceptors. Neuroscience. 1998 Jan;82(2):511-20. PubMed PMID: 9466457. 11: Bencsics A, Sershen H, Baranyi M, Hashim A, Lajtha A, Vizi ES. Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes. Brain Res. 1997 Jul 4;761(2):236-43. PubMed PMID: 9252021. 12: Jurányi Z, Orsó E, Jánossy A, Szalay KS, Sperlágh B, Windisch K, Vinson GP, Vizi ES. ATP and [3H]noradrenaline release and the presence of ecto-Ca(2+)-ATPases in the capsule-glomerulosa fraction of the rat adrenal gland. J Endocrinol. 1997 Apr;153(1):105-14. PubMed PMID: 9135575. 13: Kiss JP, Windisch K, Balla A, Sershen H, Lajtha A. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res Bull. 1997;43(3):257-62. PubMed PMID: 9227834. 14: Dóda M. Role of different subtypes of adrenoceptors in pressor responses to catecholamines released from sympathetic nerve endings. Brain Res Bull. 1997;42(1):51-7. PubMed PMID: 8978934. 15: Umeda E, Satoh T, Nagashima H, Potter PE, Tarkovács G, Vizi ES. alpha 2A subtype of presynaptic alpha 2-adrenoceptors modulates the release of [3H]-noradrenaline from rat spinal cord. Brain Res Bull. 1997;42(2):129-32. PubMed PMID: 8971417. 16: Haller J, Makara GB, Kovács JL. The effect of alpha 2 adrenoceptor blockers on aggressive behavior in mice: implications for the actions of adrenoceptor agents. Psychopharmacology (Berl). 1996 Aug;126(4):345-50. PubMed PMID: 8878351. 17: Haller J, Pintér I, Gyertyán I, Békási E, Makara GB. The differential involvement of adrenoceptors in challenges of different intensities. Neurobiology (Bp). 1996;4(1-2):111-3. PubMed PMID: 9116687. 18: Bencsics A, Elenkov IJ, Vizi ES. alpha 2-, alpha 2A-, alpha 2B/2C-Adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Res. 1995 Dec 24;705(1-2):302-6. PubMed PMID: 8821761. 19: Makara GB, Kiem DT, Vizi ES. Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat. Eur J Pharmacol. 1995 Dec 4;287(1):43-8. PubMed PMID: 8666024. 20: Haller J, Kiem DT, Makara GB. Do alpha-2 adrenoceptors modify coping strategies in rats? Psychopharmacology (Berl). 1995 Dec;122(4):379-85. PubMed PMID: 8657837.